Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by enriquesuaveon Sep 14, 2021 7:56am
306 Views
Post# 33853852

RE:RE:RE:RE:RE:Who saw the news on Providence Therapeutics today

RE:RE:RE:RE:RE:Who saw the news on Providence Therapeutics today

Thanks Eoganacht, I always thought it was Sanofi for some reason.


Eoganacht wrote: That wasn't quite right. It's on page 10 & 11 of the MD&A and Theralase is paying Alphora $939,000, which is more in line with what Theralsse has reported in the past they paid for a large batch of TLD1433.

Eoganacht wrote: In the recent MD&A on page 16 it says Theralase is paying over $400,000 to a company called Alphora Research Inc. in Mississauga. According to their website, Alphora provides API (Active Pharmaceutical Ingredient) technology development services for the scale-up of complex small molecules for Pharmaceutical and Biotechnology Companies. it sounds like they may be producing TLD1433 to Theralase.
enriquesuave wrote: Can someone confirm that TLD-1433 is manufactured by Sanofi still? Any link to this info ?  Thanks

 




<< Previous
Bullboard Posts
Next >>